Four things to know:
1. A team led by researchers at the Beijing Institute of Microbiology and Epidemiology identified Langya henipavirus, or LayV, in 35 patients in Eastern China between 2018 and 2021, all of whom had a recent history of animal exposure, according to NBC News. In 26 patients, LayV was the only potential pathogen detected.
2. Only two other henipaviruses — Hendra virus and Nipah virus — are known to infect humans. Until now, the remainder of viruses in the genus have only been detected in bats, rodents and shrews.
3. In this case, researchers suspect LayV may have jumped from shrews to humans. There is no clear evidence that the virus can spread among humans, though researchers said their sample size is too small to offer a definitive answer on transmission risks.
4. The most common symptoms among patients with a LayV infection were fever, fatigue, cough, loss of appetite, nausea, headaches and vomiting. No patients have died from their infections, according to Forbes.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
